Powered by HumanexaHumanexa Review

Editorial intelligence for pharma strategy

AnalysisResearchOpinionCalendarNewsletterAbout
Pharma StrategyDrug DevelopmentCompetitive IntelligenceAI & HealthcareBiotech BusinessIndustry Analysis

Humanexa Review

Independent editorial analysis on pharma strategy, drug development, and market structure in life sciences.

Powered by Humanexa

AboutStudioNewsletterCalendar
Explore Humanexa Intelligence Platform

Publication calendar

When we publish

Browse Humanexa Review articles by publication date. Select a highlighted day to read what we published.

August 2026

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Selected day

Monday, June 29, 2026

Industry Analysis·1 min read

Royalty Financing vs Equity for Late-Stage Assets

Non-dilutive capital structures are reshaping how pharma funds Phase 3 programs and launch preparation.

Humanexa Research